Optometry Giving Sight launches in Mexico

Article

Mexican industry leaders joined Optometry Giving Sight in Mexico to help eliminate avoidable blindness and to improve access to sustainable eye care in Mexico.

Mexico City, Mexico-Mexican industry leaders joined Optometry Giving Sight in Mexico to help eliminate avoidable blindness and to improve access to sustainable eye care in Mexico.

Leaders from the Mexican optometric and optical industry came together to celebrate the launch of the global not-for-profit organization Optometry Giving Sight in Mexico at an event in Mexico City.

Optometry Giving Sight is the only global fundraising initiative that specifically targets the prevention of blindness and impaired vision due to uncorrected refractive error-simply the need for an eye exam and glasses. It funds sustainable eye and vision care projects in underserved communities in the Americas, Asia, Africa, and Eastern Europe.

Global and local companies including Devlyn, CooperVision, Alcon, Johnson & Johnson, Essilor, Safilo, Valeant, Bausch + Lomb, Carl Zeiss Vision, Marchon, Lucy’s Optical, Groupo Europeo, Groupo Viva, Polimeros Opticos and Opticas America welcomed Optometry Giving Sight’s arrival to Mexico and unanimously pledge their support to collaborate and improve access to sustainable eye care in Mexico.

Founding partners the World Council of Optometry, Brien Holden Vision Institute, and International Agency for the Prevention of Blindness were also in attendance.

Recent Videos
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
Ali Tafreshi sits down with Optometry Times to discuss Topcon's "Healthcare from the Eye" initiative.
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
OptiLIFT in action: Dr. Julie McLaughlin's experience with the new device
© 2025 MJH Life Sciences

All rights reserved.